• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗保险受益人中射血分数保留或降低的心力衰竭的危险因素:竞争风险分析和梯度提升模型的应用

Risk Factors for Heart Failure with Preserved or Reduced Ejection Fraction Among Medicare Beneficiaries: Application of Competing Risks Analysis and Gradient Boosted Model.

作者信息

Lee Moa P, Glynn Robert J, Schneeweiss Sebastian, Lin Kueiyu Joshua, Patorno Elisabetta, Barberio Julie, Levin Raisa, Evers Thomas, Wang Shirley V, Desai Rishi J

机构信息

Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital & Harvard Medical School, Boston, MA, USA.

Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.

出版信息

Clin Epidemiol. 2020 Jun 15;12:607-616. doi: 10.2147/CLEP.S253612. eCollection 2020.

DOI:10.2147/CLEP.S253612
PMID:32606986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7304674/
Abstract

BACKGROUND

The differential impact of various demographic characteristics and comorbid conditions on development of heart failure (HF) with preserved (pEF) and reduced ejection fraction (rEF) is not well studied among the elderly.

METHODS

Using Medicare claims data linked to electronic health records, we conducted an observational cohort study of individuals ≥65 years of age without HF. A Cox proportional hazards model accounting for competing risk of HFrEF and HFpEF incidence was constructed. A gradient-boosted model (GBM) assessed the relative influence (RI) of each predictor in the development of HFrEF and HFpEF.

RESULTS

Among 138,388 included individuals, 9701 developed HF (incidence rate = 20.9 per 1000 person-years). Males were more likely to develop HFrEF than HFpEF (HR = 2.07, 95% CI: 1.81-2.37 vs. 1.11, 95% CI: 1.02-1.20, for heterogeneity <0.01). Atrial fibrillation and pulmonary hypertension had stronger associations with the risk of HFpEF (HR = 2.02, 95% CI: 1.80-2.26 and 1.66, 95% CI: 1.23-2.22) while cardiomyopathy and myocardial infarction were more strongly associated with HFrEF (HR = 4.37, 95% CI: 3.21-5.97 and 1.94, 95% CI: 1.23-3.07). Age was the strongest predictor across all HF subtypes with RI from GBM >35%. Atrial fibrillation was the most influential comorbidity for the development of HFpEF (RI = 8.4%) while cardiomyopathy was the most influential comorbidity for the development of HFrEF (RI = 20.7%).

CONCLUSION

These findings of heterogeneous relationships between several important risk factors and heart failure types underline the potential differences in the etiology of HFpEF and HFrEF.

摘要

背景

在老年人中,各种人口统计学特征和合并症对射血分数保留的心力衰竭(HFpEF)和射血分数降低的心力衰竭(HFrEF)发生发展的差异影响尚未得到充分研究。

方法

利用与电子健康记录相关联的医疗保险索赔数据,我们对年龄≥65岁且无心力衰竭的个体进行了一项观察性队列研究。构建了一个考虑HFrEF和HFpEF发病竞争风险的Cox比例风险模型。一个梯度提升模型(GBM)评估了每个预测因素在HFrEF和HFpEF发生发展中的相对影响(RI)。

结果

在纳入的138,388名个体中,9701人发生了心力衰竭(发病率=每1000人年20.9例)。男性发生HFrEF的可能性高于HFpEF(HR = 2.07,95%CI:1.81 - 2.37;相比之下,HR = 1.11,95%CI:1.02 - 1.20,异质性<0.01)。心房颤动和肺动脉高压与HFpEF风险的关联更强(HR = 2.02,95%CI:1.80 - 2.26和1.66,95%CI:1.23 - 2.22),而心肌病和心肌梗死与HFrEF的关联更强(HR = 4.37,95%CI:3.21 - 5.97和1.94,95%CI:1.23 - 3.07)。年龄是所有心力衰竭亚型中最强的预测因素,GBM的RI>35%。心房颤动是HFpEF发生发展中最有影响的合并症(RI = 8.4%),而心肌病是HFrEF发生发展中最有影响的合并症(RI = 20.7%)。

结论

这些关于几个重要危险因素与心力衰竭类型之间异质性关系的发现强调了HFpEF和HFrEF病因学上的潜在差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b1/7304674/d934f5d1a76d/CLEP-12-607-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b1/7304674/47c663c03930/CLEP-12-607-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b1/7304674/d934f5d1a76d/CLEP-12-607-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b1/7304674/47c663c03930/CLEP-12-607-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b1/7304674/d934f5d1a76d/CLEP-12-607-g0002.jpg

相似文献

1
Risk Factors for Heart Failure with Preserved or Reduced Ejection Fraction Among Medicare Beneficiaries: Application of Competing Risks Analysis and Gradient Boosted Model.医疗保险受益人中射血分数保留或降低的心力衰竭的危险因素:竞争风险分析和梯度提升模型的应用
Clin Epidemiol. 2020 Jun 15;12:607-616. doi: 10.2147/CLEP.S253612. eCollection 2020.
2
[Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].[中国实际临床实践中住院心力衰竭患者的当代流行病学与治疗]
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Nov 24;47(11):865-874. doi: 10.3760/cma.j.issn.0253-3758.2019.11.004.
3
Lifestyle and Cardiovascular Risk Factors Associated With Heart Failure Subtypes in Postmenopausal Breast Cancer Survivors.绝经后乳腺癌幸存者中心力衰竭亚型相关的生活方式和心血管危险因素
JACC CardioOncol. 2022 Mar 15;4(1):53-65. doi: 10.1016/j.jaccao.2022.01.099. eCollection 2022 Mar.
4
Atrial fibrillation and risk of incident heart failure with reduced versus preserved ejection fraction.心房颤动与射血分数降低型与射血分数保留型心力衰竭的发病风险。
Heart. 2022 Mar;108(5):353-359. doi: 10.1136/heartjnl-2021-319122. Epub 2021 May 24.
5
Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction.左心房容积和左心室质量指数在射血分数保留和降低的心力衰竭中的变化。
ESC Heart Fail. 2021 Aug;8(4):2458-2466. doi: 10.1002/ehf2.13366. Epub 2021 Jun 4.
6
Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.射血分数保留、中间范围和降低的心衰伴发的心房颤动。
JACC Heart Fail. 2017 Aug;5(8):565-574. doi: 10.1016/j.jchf.2017.05.001. Epub 2017 Jul 12.
7
Causes and Temporal Patterns of 30-Day Readmission Among Older Adults Hospitalized With Heart Failure With Preserved or Reduced Ejection Fraction.老年射血分数保留或降低的心衰患者 30 天再入院的原因及时间模式。
J Am Heart Assoc. 2018 Apr 23;7(9):e007785. doi: 10.1161/JAHA.117.007785.
8
Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.左心室射血分数正常或降低的心房颤动患者的心力衰竭进展及死亡率
J Interv Card Electrophysiol. 2019 Sep;55(3):325-331. doi: 10.1007/s10840-019-00534-x. Epub 2019 Mar 18.
9
Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort.在中国 4880 例队列中,射血分数保留、轻度降低和降低的心衰患者的 5 年死亡率。
ESC Heart Fail. 2022 Aug;9(4):2336-2347. doi: 10.1002/ehf2.13921. Epub 2022 Apr 18.
10
Sex and Race Differences in Lifetime Risk of Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction.射血分数保留的心力衰竭和射血分数降低的心力衰竭的终生风险中的性别和种族差异。
Circulation. 2018 Apr 24;137(17):1814-1823. doi: 10.1161/CIRCULATIONAHA.117.031622. Epub 2018 Jan 19.

引用本文的文献

1
Definition, Classification, Diagnosis, and Management of an Emerging Threat: Cardio-Renal-Metabolic Syndrome.一种新出现的威胁:心肾代谢综合征的定义、分类、诊断及管理
Am J Cardiovasc Drugs. 2025 Aug 26. doi: 10.1007/s40256-025-00761-w.
2
A Retrospective Comparative Study of Sex-Based Risk Variations in Heart Failure With Preserved Ejection Fraction (HFpEF) Versus Heart Failure With Reduced Ejection Fraction (HFrEF).射血分数保留的心力衰竭(HFpEF)与射血分数降低的心力衰竭(HFrEF)基于性别的风险差异的回顾性比较研究。
J Prim Care Community Health. 2025 Jan-Dec;16:21501319251367840. doi: 10.1177/21501319251367840. Epub 2025 Aug 22.
3

本文引用的文献

1
Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction.射血分数保留和降低的心衰发病率和死亡率的时间趋势。
JACC Heart Fail. 2018 Aug;6(8):678-685. doi: 10.1016/j.jchf.2018.03.006. Epub 2018 Jul 11.
2
Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association.《2018年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2018 Mar 20;137(12):e67-e492. doi: 10.1161/CIR.0000000000000558. Epub 2018 Jan 31.
3
Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction.
Comorbidities and incidence of heart failure with preserved ejection fraction: a systematic review and meta-analysis of cohort studies.
射血分数保留的心力衰竭的合并症与发病率:队列研究的系统评价和荟萃分析
BMJ Open. 2025 Aug 1;15(7):e093306. doi: 10.1136/bmjopen-2024-093306.
4
Gender-Specific Differences in Diastolic Dysfunction and HFpEF: Pathophysiology, Diagnosis, and Therapeutic Strategies.舒张功能障碍和射血分数保留的心力衰竭中的性别差异:病理生理学、诊断和治疗策略。
J Cardiovasc Dev Dis. 2025 Jun 5;12(6):213. doi: 10.3390/jcdd12060213.
5
Cardiovascular, Kidney, Liver, and Metabolic Interactions in Heart Failure: Breaking Down Silos.心力衰竭中的心血管、肾脏、肝脏及代谢相互作用:打破壁垒
Circ Res. 2025 May 23;136(11):1170-1207. doi: 10.1161/CIRCRESAHA.125.325602. Epub 2025 May 22.
6
Risk factors of mortality among heart failure patients in Jordan: the Jordanian Heart Failure Registry (JoHFR).约旦心力衰竭患者的死亡风险因素:约旦心力衰竭登记处(JoHFR)。
Ann Med Surg (Lond). 2025 Apr 4;87(5):2659-2667. doi: 10.1097/MS9.0000000000003255. eCollection 2025 May.
7
Epicardial Fat in Heart Failure and Preserved Ejection Fraction: Novel Insights and Future Perspectives.射血分数保留的心力衰竭中的心外膜脂肪:新见解与未来展望
Curr Heart Fail Rep. 2025 Mar 19;22(1):13. doi: 10.1007/s11897-025-00700-5.
8
Potential of Sodium-Glucose Cotransporter-2 Inhibitors in the Management of Heart Failure With Preserved Ejection Fraction: A Narrative Review.钠-葡萄糖协同转运蛋白2抑制剂在射血分数保留的心力衰竭管理中的潜力:一项叙述性综述
Cureus. 2024 Nov 18;16(11):e73906. doi: 10.7759/cureus.73906. eCollection 2024 Nov.
9
Risk of Incident Heart Failure and Heart Failure Subtypes in Patients With Rheumatoid Arthritis.类风湿关节炎患者发生心力衰竭及心力衰竭亚型的风险
Arthritis Care Res (Hoboken). 2025 May;77(5):631-639. doi: 10.1002/acr.25481. Epub 2025 Jan 16.
10
Heart failure subtype after acute kidney injury.急性肾损伤后的心力衰竭亚型。
BMC Nephrol. 2024 May 17;25(1):167. doi: 10.1186/s12882-024-03602-1.
心血管生物标志物与射血分数保留和降低的心力衰竭事件的相关性。
JAMA Cardiol. 2018 Mar 1;3(3):215-224. doi: 10.1001/jamacardio.2017.4987.
4
Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials.β受体阻滞剂治疗射血分数降低、中间范围和保留的心衰:双盲随机试验的个体患者水平分析。
Eur Heart J. 2018 Jan 1;39(1):26-35. doi: 10.1093/eurheartj/ehx564.
5
Identifying Patients With High Data Completeness to Improve Validity of Comparative Effectiveness Research in Electronic Health Records Data.确定数据完整性高的患者,以提高电子健康记录数据中比较有效性研究的有效性。
Clin Pharmacol Ther. 2018 May;103(5):899-905. doi: 10.1002/cpt.861. Epub 2017 Oct 10.
6
Epidemiology of heart failure with preserved ejection fraction.射血分数保留型心力衰竭的流行病学。
Nat Rev Cardiol. 2017 Oct;14(10):591-602. doi: 10.1038/nrcardio.2017.65. Epub 2017 May 11.
7
Heart failure labelled patients with missing ejection fraction in primary care: prognosis and determinants.初级保健中射血分数缺失的心力衰竭标记患者:预后和决定因素
BMC Fam Pract. 2017 Mar 17;18(1):38. doi: 10.1186/s12875-017-0612-6.
8
Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Vicious Twins.射血分数保留的心力衰竭与心房颤动:罪恶双生子。
J Am Coll Cardiol. 2016 Nov 15;68(20):2217-2228. doi: 10.1016/j.jacc.2016.08.048.
9
Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭的临床表型
J Am Heart Assoc. 2016 Jan 25;5(1):e002477. doi: 10.1161/JAHA.115.002477.
10
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction.射血分数对射血分数保留的心力衰竭患者使用螺内酯的疗效及预后的影响。
Eur Heart J. 2016 Feb 1;37(5):455-62. doi: 10.1093/eurheartj/ehv464. Epub 2015 Sep 15.